IC
Ikove Capital Partners
Micro VCActiveConcept Stage Technology Investor partnering with leading US Universities to bring to market disruptive technologies
10
Investments
4
Exits
$250M
AUM
40.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ikove Capital Partners.
Investment Thesis & Strategy
Ikove Capital Partners invests in concept-stage disruptive technologies, particularly in fintech, partnering with US universities to commercialize innovative solutions. They focus on identifying and supporting early-stage ventures with high growth potential.
Investment Activity
Deals per year over the last 4 years
3
20180
20193
20203
2021Portfolio Companies
Selected investments from their portfolio of 10 companies
A
Acrelec
Robotics · Growth, 2021
A
Acrelec
Robotics · Growth, 2021
A
Acrelec
Robotics · Growth, 2021
V
Ventech Solutions
Healthcare · Growth, 2020
V
Ventech Solutions
Healthcare · Growth, 2020
V
Ventech Solutions
Healthcare · Growth, 2020
P
PathogenDx
Biotech · Series A, 2018
P
PathogenDx
Biotech · Series A, 2018
P
PathogenDx
Biotech · Series A, 2018
Notable Exits
CompanyTypeYearValue / Acquirer
Path RoboticsAcquisition2024—
Upward HealthAcquisition2023—
TegoAcquisition2023—
Ventech SolutionsAcquisition2022—
Frequently Asked Questions
Ikove Capital Partners focuses on Seed, Series A stage investments.
Related Investors
NCT Ventures
Columbus, United States · 47 deals
10Xelerator
Columbus, United States · 21 deals
Break Trail Ventures
Columbus, United States · 18 deals
LOUD Capital
Columbus, United States · 10 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals